Bionomics is a fully integrated, international drug discovery and development company creating new therapies that serve large unmet needs in cancer and central nervous system (CNS) disorders. Based in Adelaide, Australia with operations in San Diego, USA and a wholly owned subsidiary in Strasbourg, France, Bionomics is listed on the Australian Securities Exchange (ASX) under the code BNO, and the US OTCQX market under the code BNOEF.

ASX Announcements

  • Executive Chairman Extension of Appointment

    15 March 2019

    Download PDF

  • Further Analysis of Phase 2 PTSD Results

    18 February 2019

    Download PDF

  • Further Analysis of Phase 2 PTSD Trial Results Presentation

    18 February 2019

    Download PDF

LATEST CORPORATE PRESENTATION

Latest Analyst Report